Clinical trial
A Study of ddI in Children With AIDS Who Have Not Had Success With Zidovudine
NCT00002280 · Bristol-Myers Squibb, Industry · Completed
Key facts
| NCT number | NCT00002280 |
|---|---|
| Title | A Study of ddI in Children With AIDS Who Have Not Had Success With Zidovudine |
| Official title | An Open Label Study Regimen of Videx (2',3'-Dideoxyinosine, ddI) in Children With Acquired Immunodeficiency Syndrome (AIDS) Who Have Demonstrated Significant Deterioration or Intolerance to Zidovudine (Retrovir) |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Didanosine |
| Completion | Nov 1, 1994 |
| First posted | Aug 31, 2001 |
| Last update posted | Aug 5, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: